OmniActive Health Technologies’ Post

Lutein For Every Age is kicking it up a notch! Want to find out how we are educating consumers AND healthcare practitioners? Contact me and let's discuss how to leverage this initiative to reach your target audiences. #LuteinForEveryAge #Lutein #Zeaxanthin #LutemaxKids #Lutemax2020 #AnEyeOnAHealthySchoolYear #BackToSchool #Supplements #NaturalProducts

Starting today.... Prevention is the way

𝗗𝗿𝗮𝗳𝘁 𝗘𝗙𝗦𝗔 𝗼𝗽𝗶𝗻𝗶𝗼𝗻 𝗼𝗻 𝘁𝗼𝗹𝗲𝗿𝗮𝗯𝗹𝗲 𝘂𝗽𝗽𝗲𝗿 𝗶𝗻𝘁𝗮𝗸𝗲 𝗹𝗲𝘃𝗲𝗹 𝗳𝗼𝗿 𝘃𝗶𝘁𝗮𝗺𝗶𝗻 𝗘. European Food Safety Authority (EFSA) has published its draft guidance on the tolerable uper intake level for vitamin E. No change si proposed for UL for adults and children > 1 years. EFSA proposes new UL for children 4-12 months. The UL set up by EFSA are: 50 mg/day for infants 4-6 months, 60 mg/day for infants 7-11 months, 100 mg/day for children 1-3 years, 120 mf/day for 4-6 years, 160 mg/day for 7-10 years, 200 mg/day for 11-14 years, 260 mg/day for 15-17, and 300 mg/day for adults, including pregnant and breastfeeding women. ULs apply for all stereoisomeric forms of α-tocopherol. However, ULs do not apply to individuals receiving anticoagulant or antiplatelet medications (e.g., aspirin), to patients on secondary prevention for CVD, or to patients with vitamin K malabsorption syndromes. The draft opinion is open for public consultation until 09/06/2024. https://lnkd.in/getqBYsP #EFSA #VitaminE #Upperlimit #Supplement #FoodchainID

The recommendations from on sodium valproate and mesh are so depressing. What makes me feel particularly angry is that the risks of SV have been know for decades and safer alternatives have been available for years. Why are these medicines prescribed for women who might fall pregnant? Why aren't the warnings on medicines packing prominent and clear? There is a lot of focusing of digitising the patient information leaflets enclosed with medicines. We know that only around 40% of people understand the lengthy small print. The first priority should be to make the risks and benefits of medicines crystal clear. This is a regulatory issue which needs to be urgently addressed to improve patient safety.

Compounding pharmacies are able to provide clinicians with a variety of options of medication dosage forms for their pediatric patients. Common preparations are seen in liquid and topical forms. Freezer pops, gummy chews, and lollipops can be made containing different medicines depending on patient need. These medications can also be flavored according to patient preference. https://lnkd.in/gtcbhShr #VillageCompoundingPharmacy #CompoundingPharmacy #Wellness #HealthandWellness #Postmenopause #Perimenopause #Premenopause #WomensHealth #WomensHealthandWellness #HormoneReplacementTherapy #HormoneReplacement #Compounding #CustomMedications #PersonalizedMedicine

Precision, personalization, and quality - the pillars of compounding pharmacies. https://lnkd.in/gtcbhShr #VillageCompoundingPharmacy #CompoundingPharmacy #Wellness #HealthandWellness #Postmenopause #Perimenopause #Premenopause #WomensHealth #WomensHealthandWellness #HormoneReplacementTherapy #HormoneReplacement #Compounding #CustomMedications #PersonalizedMedicine

Awareness and early action are key to supporting those affected. Let’s work together to spread knowledge and offer support. 💡🧠 #WorldAlzheimersDay #AlzheimersDisease #Dementia #SunnyD #VitaminD #Supplements #DDukaan #LivetheSunnyDLife #YourDefenceStartsWithD #HealthAndWellness #ScotmannPharmaceuticals 

Why are older patients embracing #cannabis to complement their medical care? Check out my video on you Youtube channel. #marijuana #medicine #nursing #healthcare https://lnkd.in/e8eY7uNi

Today (September 20), the Australian Competition and Consumer Commission (ACCC) announced its proposal to deny the authorisation sought by the Infant Nutrition Council for the ‘Marketing in Australia of Infant Formula: Manufacturers and Importers Agreement’ (MAIF Agreement). The ACCC expressed concerns that the voluntary code no longer delivers sufficient public benefits to outweigh the potential public detriment. Key Highlights: - MAIF Agreement: A voluntary code aimed at restricting the promotion of infant formula to protect and promote breastfeeding rates in Australia. - ACCC Concerns: The ACCC highlighted issues with the code’s voluntary nature, limited scope, and its inability to effectively regulate modern digital marketing practices, such as social media and influencer content. - Future of Regulation: An independent review recommended replacing the MAIF Agreement with a stronger, mandatory regulatory framework, a suggestion the Australian Government is currently considering. The ACCC is seeking submissions on this draft determination by October 17, 2024, before making its final decision. For more updates on competition and consumer protection regulations, unlock cutting-edge legal intelligence with our subscription free platform — join us today. Visit https://lnkd.in/gZmkUPim to know more. #CompetitionLaw #ConsumerProtection #InfantNutrition #ACCC #Regulation #GRI